In diabetes treatment, patchoulol inhibits crucial pathways, such as activating transcription factor 6 (ATF6), inositol-requiring enzyme 1 (IRE1), protein kinase RNA-like ER kinase (PERK), and Wnt/β-catenin. This evidence concerns the gene ERN1 and diabetes mellitus.